Glen Eagle Advisors, LLC Neogenomics Inc Transaction History

Glen Eagle Advisors, LLC

$593 Billion
Q3 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 19,500 shares of NEO stock, worth $335,010. This represents 0.05% of its overall portfolio holdings.

Number of Shares

19,500

Previous 19,500 -0.0%

Holding current value

$335,010

Previous $270 Million 6.34%

% of portfolio

0.05%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $11,058 - $13,404	-850 Reduced 4.18%	19,500 $270 Million
Q1 2024 Jul 03, 2024	BUY	$14.06 - $16.79 $274,170 - $327,405	19,500 New	19,500 $307 Million
Q4 2021 Aug 13, 2024	SELL	$30.49 - $48.49 $142,540 - $226,690	-4,675 Reduced 19.34%	19,500 $665 Million
Q3 2021 Aug 13, 2024	BUY	$41.66 - $52.52 $145,810 - $183,820	3,500 Added 16.93%	24,175 $1.17 Billion
Q1 2021 Aug 13, 2024	SELL	$41.56 - $59.88 $2,078 - $2,994	-50 Reduced 0.24%	20,675 $997 Million
Q4 2020 Aug 13, 2024	BUY	$36.08 - $56.47 $44,198 - $69,175	1,225 Added 6.28%	20,725 $1.12 Billion
Q4 2019 Aug 13, 2024	BUY	$18.96 - $29.84 $4,740 - $7,460	250 Added 1.22%	20,725 $606 Million
Q3 2019 Aug 13, 2024	BUY	$19.12 - $26.24 $4,302 - $5,904	225 Added 1.11%	20,475 $391 Million
Q1 2019 Aug 13, 2024	BUY	$12.14 - $20.46 $9,105 - $15,345	750 Added 3.85%	20,250 $414 Million
Q3 2018 Aug 13, 2024	SELL	$12.5 - $15.38 $1,250 - $1,538	-100 Reduced 0.49%	20,250 $311 Million
Q1 2018 Aug 14, 2024	BUY	$7.23 - $8.76 $6,145 - $7,446	850 Added 4.36%	20,350 $166 Million
Q3 2017 Aug 13, 2024	BUY	$9.11 - $11.26 $7,743 - $9,571	850 Added 4.36%	20,350 $226 Million
Q4 2016 Aug 12, 2024	BUY	N/A	850	20,350 $174 Million

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.16B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Neogenomics Inc Transaction History